Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma
Details
Publication Year 2023-08,Volume 53,Issue #8,Page 1469-1477
Journal Title
Internal Medicine Journal
Publication Type
Guideline
Abstract
Infection remains a significant contributor to morbidity and mortality in patients with myeloma. This guideline was developed by a multidisciplinary group of clinicians who specialise in the management of patients with myeloma and infection from the medical and scientific advisory group from Myeloma Australia and the National Centre for Infections in Cancer. In addition to summarising the current epidemiology and risk factors for infection in patients with myeloma, this guideline provides recommendations that address three key areas in the prevention of infection: screening for latent infection, use of antimicrobial prophylaxis and immunoglobulin replacement and vaccination against leading respiratory infections (severe acute respiratory syndrome coronavirus 2, influenza and Streptococcus pneumoniae) and other preventable infections. This guideline provides a practical approach to the prevention of infection in patients with myeloma and harmonises the clinical approach to screening for infection, use of prophylaxis and vaccination to prevent infectious complications.
Publisher
Wiley
Keywords
Humans; *Anti-Infective Agents; Consensus; *COVID-19/complications; *Multiple Myeloma/complications/drug therapy; Vaccination; guidelines; infection; myeloma; prevention
Department(s)
Infectious Diseases; Clinical Haematology; Health Services Research
PubMed ID
37093163
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-11-14 12:41:58
Last Modified: 2024-07-30 01:39:35

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙